Enhancing HIV vaccine trial consent preparedness among street drug users

Journal of Empirical Research on Human Research Ethics

Volumn 5, Issue 2, 2010, Pages 65-80

  Fisher, Celia B ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

Addiction; Ethics; HIV risk; Informed consent; Intravenous drug use; Trust; Vaccine trials

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; STREET DRUG;

ADDICTION; ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; ETHICS; FEMALE; HUMAN; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENT SELECTION; RISK; TRUST; UNITED STATES;

ADULT; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; RISK; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TRUST; UNITED STATES;

EID: 77953975981     PISSN: 15562646     EISSN: 15562654     Source Type: Journal    
DOI: 10.1525/jer.2010.5.2.65     Document Type: Article

References (73)

1. ALLEN, M., LIANG, T. S., SALVIA, T. L., TJUGUM, B., GULAKOWSKI, R. J. & MURGUIA, M. (2005). Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Journal of Acquired Immune Deficiency Syndromes, 40 (5), 617-624.
2. APPELBAUM, P. S., LIDZ, W. L., & GRISSO T. (2004). Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research, 26 (2), 1-8.
3. BARAL, S., SHERMAN, S., MILLSON, P., & BEYRER, C. (2007). Vaccine immunogenicity in injecting drug users: A systematic review. Lancet Infectious Diseases, 7 (10), 667-674.
4. BEYRER, C. (2002). Injecting drug users and HIV vaccine trials: What does the science say? AIDScience, 2 (14), 1771-1782.
5. BLENDON, R. J., BUHR, T., CASSIDY, E. F., PEREZ, D. J., HUNT, K. A., FLEISCHFRESSER, C., BENSON, J. M., & HERRMANN, M. J. (2007). Disparities in health: Perspectives of a multi-ethnic, multi-racial America. Health Affairs, 26 (5), 1437-1447.
6. ALLEN, M., LIANG, T. S., SALVIA, T. L., TJUGUM, B., GULAKOWSKI, R. J. & MURGUIA, M. (2005). Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Journal of Acquired Immune Deficiency Syndromes, 40 (5), 617-624.
7. APPELBAUM, P. S., LIDZ, W. L., & GRISSO T. (2004). Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research, 26 (2), 1-8.
8. BARAL, S., SHERMAN, S., MILLSON, P., & BEYRER, C. (2007). Vaccine immunogenicity in injecting drug users: A systematic review. Lancet Infectious Diseases, 7 (10), 667-674.
9. BEYRER, C. (2002). Injecting drug users and HIV vaccine trials: What does the science say? AIDScience, 2 (14), 1771-1782.
10. BLENDON, R. J., BUHR, T., CASSIDY, E. F., PEREZ, D. J., HUNT, K. A., FLEISCHFRESSER, C., BENSON, J. M., & HERRMANN, M. J. (2007). Disparities in health: Perspectives of a multi-ethnic, multi-racial America. Health Affairs, 26 (5), 1437-1447
11. BOULWARE, L. E., COOPER, L. A., RATNER, L. E., LAVEIST, T. A., & POWE, N. R. (2003). Race and trust in the health care system. Public Health Reports, 118 (4), 358-365.
12. BROOKS, R. A., NEWMAN, P. A., DUAN, N., & ORTIZ, D. J. (2007). HIV vaccine trial preparedness among Spanishspeaking Latinos in the US. AIDS Care, 19 (1), 52-58.
13. BUCHBINDER, S. P., METCH, B., HOLTE, S. E., SCHEER, S., COLETTI, A., & VITTINGHOFF, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36 (1), 604-612.
14. Centers for Disease Control and Prevention, U. S. Department of Health and Human Services. (2009). Deaths among persons with AIDS through December 2006. HIV/AIDS Surveillance Supplemental Report, 14 (3), 4. Retrieved March 2, 2010 from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2009supp- vol14no3/default.htm.
15. COLETTI, A. S., HAEGERTY, P., SHEON, A. R., GROSS, M., KOBLIN, B. A., METZER, D. S., & SEAGE, G. R. (2003). Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes, 32 (2), 161-169.
16. COLFAX, G., BUCHBINDER, S., VAMSHIDAR, G., CELUM, C., MCKIRNAN, D., NEIDIG, J., KOBLIN, B., GURWITH, M., & BARTHOLOW, B. (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 39 (3), 359-364.
17. CORBIE-SMITH, G., THOMAS, S. B., WILLIAMS, M. V., & MOODY-AYERS, S. (1999). Attitudes and beliefs of African Americans toward participation in medical research. Journal of General Internal Medicine, 14 (9), 537-546.
18. CRAWLEY, L. M. (2001). African American participation in clinical trials: Situating trust and trustworthiness. Journal of the National Medical Association, 93 (14 Suppl.), 14S-17S.
19. DHALLA, S., WOODS, R., STRATHDEE, S. A., PATRICK, D. M., & HOGGS, R. S. (2007). HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. AIDS Care, 19 (9), 1118-1127.
20. DJOMAND, G., METCH, B., ZORRILLA, C. D., DONASTORG, Y., CASAPIA, M., VILLAFANA, T., PAPE, J., FIGUEROA, P., HANSEN, M., BUCHBINDER, S., & BEYRER, C. for the 903 Protocol Team. (2008). The HVTN protocol 903 vaccine preparedness study: Lessons learned in preparation for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes, 48 (1), 82-89.
21. DOLIN, R. (2009). HIV vaccine trial results: An opening for further research. New England Journal of Medicine, 361 (23), 2279-2280.
22. DORMANDY, E., MICHIE, S., HOOPER, R., & MARTEAU, T. M. (2006). Informed choice in antenatal Down syndrome screening: A cluster-randomised trial of combined versus separate visit testing. Patient Education and Counseling, 61 (1), 56-64.
23. EMANUEL, E. J. (2005). Undue inducement: Nonsense on stilts? American Journal of Bioethics, 5 (5), 9-13.
24. EXCLER, J.-L., KOCHHAR, S., KAPOOR, S., DAS, S., BAHRI, J., GHOSH, M. D., GANGULY, N. K., NAYYAR, A., & CHATAWAY, M. (2008). Preparedness for AIDS vaccine trials in India. Indian Journal of Medical Research, 127 (6), 531-538.
25. FISHER, C. B. (1999). Relational ethics and research with vulnerable populations In Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity, Vol. 2: Commissioned Papers by the National Bioethics Advisory Commission (pp. 29-49). Rockville, MD: National Bioethics Advisory Commission. Retrieved December 4, 2009 from http://bioethics.georgetown.edu/ nbac/pubs.html.
26. FISHER, C. B. (2002). A goodness-of-fit ethic of informed consent. Urban Law Journal, 30 (1), 159-171.
27. FISHER, C. B. (2003). A goodness-of-fit ethic for informed consent to research involving persons with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 9 (1), 27-31.
28. FISHER, C. B. (2004). Ethics in drug abuse and related HIV risk research. Applied Developmental Science, 8 (2), 91-102.
29. FISHER, C. B. & GOODMAN, S. J. (2009). Goodness-of-fit ethics for non-intervention research involving dangerous and illegal behaviors. In D. Buchanan, C. B. Fisher, & L. Gable (Eds.), Research with High-risk Populations: Balancing Science, Ethics, and Law (pp. 25-46). Washington, DC: American Psychiatric Association.
30. FISHER, C. B., ORANSKY, M., MAHADEVAN, M., SINGER, M., MIRHEJ, G. & HODGE, D. (2008). Marginalized populations and drug addiction research: Realism, Mistrust, and Misconception. " IRB: Ethics & Human Research, 30 (3), 1-9.
31. FISHER, C. B. & RAGSDALE, K. (2006). A goodness-of-fit ethics for multicultural research. In J. Trimble & C. B. Fisher (Eds.), The Handbook of Ethical Research with Ethnocultural Populations and Communities (pp. 3-26). Thousand Oaks, CA: Sage.
32. FISHER, C. B. & WALLACE, S. A. (2000). Through the community looking glass: Re-evaluating the ethical and policy implications of research on adolescent risk and psychopathology. Ethics & Behavior, 10 (2), 99-118.
33. FRY, C. L. & DWYER, R. (2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96 (9), 1319-1325.
34. FRY, C. L., HALL, W., RITTER, A., & JENKINSON, R. (2006). The ethics of paying drug users who participate in research: A review and practical recommendations. Journal of Empirical Research on Human Research Ethics, 1 (4), 21-36.
35. GAMBLE, V. N. (1997). Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health, 87 (11), 1773-1778.
36. GOLUB, E. T., PURVIS, L. A., SAPUN, M., SAFAEIAN, M., BEYRER, C., VLAHOV, D., & STRATHDEE, S. A. (2005). Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS and Behavior, 9 (3), 301-309.
37. GORELICK, D. A., PICKENS, R. W., & BONKOVSKY, F. O. (1999). Clinical research in substance abuse: Human subjects issues. In H. A. Pincus, J. A. Lieberman, & S. Ferris (Eds.), Ethics in Psychiatric Research (pp. 177-192). Washington, DC: American Psychiatric Association.
38. GRADY, C., WAGMAN, J., SSEKUBUGU, R., WAWER, M. J., SERWADDA, D., KIDDUGAVU, M., NALUGODA, F., GRAY, R. H., WENDLER, D., DONG, Q., DIXON, D. O., TOWNSEND, B., WAHL, E., & EMANUEL, E. J. (2008). Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District. IRB: Ethics & Human Research, 30 (2), 1-7.
39. HALPERN, S. D., METZGER, D. S., BERLIN, J. A., & UBEL., P. A. (2001). Who will enroll? Predicting participation in a phase II AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndromes, 27 (3), 281-288.
40. HIGGS, P., MOORE, D., & AITKEN, C. (2006). Engagement, reciprocity and advocacy: Ethical harm reduction practice in research with injecting drug users. Drug and Alcohol Review, 25 (5), 419-423.
41. HIV Vaccine Trials Network. (2010). Global HVTN Sites. Retrieved January 19, 2010, from http://www.hvtn.org/about/sites.html.
42. IRWIN, K. S. & FRY, C. L. (2007). Strengthening drug policy and practice through ethics engagement: An old challenge for a new harm reduction. International Journal of Drug Policy, 18 (2), 75-83.
43. JENKINS, R. A., TORUGSA, K., MARKOWITZ, L. E., MASON, C. J., JAMROENTANA, V., BROWN, A. E., & NITAYAPHAN, S. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76 (5), 386-392.
44. KLITZMAN, R. (2008). Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees. Developing World Bioethics, 8 (3), 207-218.
45. KOBLIN, B. A., HOLTE, S., LENDERKING, B. & HEAGERTY, R. (2000). Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. Journal of Acquired Immune Deficiency Syndromes, 24 (5), 451-457.
46. LAGAKOS, S. W. & GABLE, A. R. (EDS.) (2008). Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press.
47. LAU, C.-Y., CARDINALI, M., SATO, P. A., FIX, A., & FLORES, J. (2008). Broadening inclusion of vulnerable populations in HIV vaccine trials. Expert Review of Vaccines, 7 (2), 259-268.
48. LAZOVSKI, J., LOSSO, M., KROHMAL, B., EMANUEL, E. J., GRADY, C., & WENDLER, D. (2009). Benefits and burdens of participation in a longitudinal clinical trial. Journal of Empirical Research on Human Research Ethics, 4 (3), 89-97.
49. LEVINE, R. J. (1988). Ethics and Regulation of Clinical Research, 2nd ed. New Haven, CT: Yale University Press.
50. MAHER, L. WHITE, B., DONALD, A., BATES, A., ENRIQUEZ, J., PHAM, S., & LIAO, L. (2010). Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs. International Journal of Drug Policy, 21 (3), 194-201.
51. MASTY, J. & FISHER, C. (2008). A goodness-of-fit approach to informed consent for pediatric intervention research. Ethics & Behavior, 18 (2/3), 139-160.
52. MCCRADY, B. S. & BUX, D. A., JR. (1999). Ethical issues in informed consent with substance abusers. Journal of Consulting and Clinical Psychology, 67 (2), 186-193.
53. MCDONALD, M., TOWNSEND, A., COX, S. M., PATERSON, N. D., & LAFRENIÈRE, D. (2008). Trust in health research relationships: Accounts of human subjects. Journal of Empirical Research on Human Research Ethics, 3 (4), 35-47.
54. MEYERS, K., METZGER, D. S., NAVALINE, H., WOODY, G. E., & MCLELLAN, A. T. (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84 (5), 761-766.
55. MIDDELKOOP, K., MYER, L., MARK, D., MTHIMUNYE, S. P., SMIT, J., WOOD, R., & BEKKER, L.-G. (2008). Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. Journal of Adolescent Health, 43 (1), 8-14.
56. MILLS, E., COOPER, C., GUYATT, G., GILCHRIST, A., RACHLIS, B., SULWAY, C., & WILSON, K. (2004). Barriers to participating in an HIV vaccine trial: A systemic review. AIDS, 18 (17), 2235-2242.
57. National Institute of Allergy and Infectious Diseases (NIAID). (2009). HIV Vaccine Awareness Day: Fact Sheets, Brochures, and Questions & Answers. Retrieved November 13, 2009 from http://www3.niaid.nih.gov/news/events/HVAD/ publications/factsheet.htm.
58. NEWMAN, P. A., DUAN, N., KAKINAMI, L., & ROBERTS, K. (2008). What can HIV vaccine trials teach us about future HIV vaccine dissemination? Vaccine, 26 (20), 2528-2536.
59. ORANSKY, M., FISHER, C. B., MAHADEVAN, M., & SINGER, M. (2009). Barriers and opportunities for recruitment for nonintervention studies on HIV risk: Perspectives of street drug users. Substance Use & Misuse, 44 (11), 1642-1659.
60. PRIDDY, F. H., CHENG, A. C., SALAZAR, L. F., & FREW, P. M. (2006). Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. International Journal of STD & AIDS, 17 (2), 99-102.
61. RIPLEY, E. B. D. (2006). A review of paying research participants: It's time to move beyond the ethical debate. Journal of Empirical Research on Human Research Ethics, 1 (4), 9-19.
62. SEAL, K. H., KRAL, A. H., LORVICK, J., MCNEES, A., GEE, L., & EDLIN, B. R. (2003). A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug and Alcohol Dependence, 71 (2), 127-131.
63. SEDDON, T. (2005). Paying drug users to take part in research: Justice, human rights, and business perspectives on the use of incentive payments. Addiction Research & Theory, 13 (2), 101-109.
64. SINGER, E. & COUPER, M. P. (2008). Do incentives exert undue influence on survey participation? Experimental evidence. Journal of Empirical Research on Human Research Ethics, 3 (3), 49-56.
65. SLOMKA, J., MCCURDY, S., RATLIFF, E. A., TIMPSON, S., & WILLIAMS, M. L. (2007). Perceptions of financial payment for research participation among African-American drug users in HIV studies. Journal of General Internal Medicine, 22 (10), 1403-1409.
66. SOBIESZCZYK, M. E., XU, G., GOODMAN, K., LUCY, D., & KOBLIN, B. A. (2009). Engaging members of African American and Latino communities in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes, 51 (2), 194-201.
67. STRILEY, C. L. W., CALLAHAN, C., & COTTLER, L. B. (2008). Enrolling, retaining, and benefiting out-of treatment drug users in intervention. Journal of Empirical Research on Human Research Ethics, 3 (3), 19-25.
68. SUNTHARASAMAI, P., MARTIN, M., VANICHSENI, S., VAN GRIENSVEN, F., MOCK, P. A., PITISUTTITHUM, P., TAPPERO, J. W., SANGKUM, U., KITAYAPORN, D., GURWITH, M., & CHOOPANYA, K. (2009). Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Addiction, 104 (2), 235-242.
69. UNAIDS. (2007). Meeting Ethical Concerns over HIV Trials. Retrieved January 19, 2010 from http://www.unaids.org/en/KnowledgeCentre/Resources/ FeatureStories/archive/2007/20071203-ethical-concerns-HIV-trials.asp.
70. °B/E HIV vaccine trial in Bangkok, Tailand. AIDS, 18 (2), 295-301.
71. VALENTE, T. W., ZOGG, J. B., CHRISTENSEN, S., RICHARDSON, J., KOVACS, A., & OPERSKALSKI, E. (2009). Using social networks to recruit an HIV vaccine preparedness cohort. Journal of Acquired Immune Deficiency Syndrome, 52 (4), 514-523.
72. VLAHOV, D., ASTEMBORSKI, J., SOLOMON, L., GALAI, N., BASARAB, L., & NELSON, K. E. (1994). Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Research and Human Retroviruses, 10 (Suppl. 2), S265-S268. (Pubitemid 24375479)
73. YIN, L., ZHANG, Y., QIAN, H.-Z., RUI, B., ZHANG, L., ZHU, J., GUAN, Y., WANG, Y., LI, Q., RUAN, Y., & SHAO, Y. (2008). Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine, 26 (6), 762-768.